Low-level exposure to cadmium during the lifetime increases the risk of osteoporosis and fractures of the lumbar spine in the elderly: studies on a rat model of human environmental exposure.
In this study, based on a rat model of human environmental exposure to cadmium (Cd), it has been examined whether low-level lifetime Cd exposure increases the risk of vertebral osteoporosis and vertebrae fractures in the elderly. For this purpose, the lumbar vertebral bodies (L4 or L3) of control and Cd-exposed (1 mg Cd/l in drinking water for 24 months) female Wistar rats were assigned to densitometric, radiographic, biomechanical (compression test), and biochemical studies, as well as to assess their dimensions and chemical composition. The exposure to Cd affected the mineral status of the L4. The decreased mineral content, density (BMD) and bone mineral area of the vertebral body together with the unchanged ratio of non-organic and organic components indicate osteoporotic nature of the Cd-induced changes. The activity of alkaline phosphatase in the L3 decreased. Cd also influenced the mechanical properties of the L4. The yield load and ultimate load decreased indicating a weakness in the vertebral body compression strength. Stiffness of the L4 decreased and the displacement at ultimate increased suggesting its enhanced susceptibility to deformities. Indeed, in the Cd group vertebral deformities (in 30% of females) or even fractures (in 40% of females), including those with disruption of bone continuity were evident. Z-score values for the L4 BMD revealed vertebral osteopenia in 30% and osteoporosis in 70% of the Cd-exposed females. The results allow for the conclusion that low lifetime exposure to Cd may become an important factor increasing the risk of lumbar spine osteoporosis with vertebral deformities and fractures in the elderly.
Brzóska
Malgorzata M
MM
Department of Toxicology, Medical University of Białystok, Mickiewicza 2C street, 15-222 Białystok, Poland. mmbr@poczta.onet.pl
Moniuszko-Jakoniuk
Janina
J
D000469:Alkaline Phosphatase / Q000032:analysis / Q000378:metabolism; D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001851:Bone Diseases, Metabolic / Q000139:chemically induced / Q000453:epidemiology / Q000473:pathology; D001842:Bone and Bones / Q000737:chemistry; D002104:Cadmium / Q000633:toxicity* / Q000652:urine; D004435:Eating; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D008954:Models, Biological; D010024:Osteoporosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000453:epidemiology*; D011859:Radiography; D051381:Rats; D017208:Rats, Wistar; D016103:Spinal Fractures / Q000453:epidemiology*; D013131:Spine / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D013314:Stress, Mechanical; D014881:Water Supply; D015430:Weight Gain / Q000187:drug effects; D016474:Weight-Bearing
D002104:Cadmium; D000469:Alkaline Phosphatase